Neuland Laboratories (Hyderabad, India), a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates, and contract manufacturing services, says it has entered into a manufacturing collaboration with API Corp. (Tokyo), a subsidiary of Mitsubishi Chemical that produces APIs, intermediates, and investigational new drugs, along with fine chemicals and reagents. API Corp., under the terms of the agreement, is making an investment in Neuland’s facilities that will provide API Corp. with dedicated capacity for meeting...